tert-Butyl 1-(5-aminopyridin-2-yl)piperidin-4-ylcarbamate, 95.0%, 1g

2-CHLORO-5-(DIFLUOROMETHYL)-4-METHYLPYRIDINE, 98%, 5g

(4-Fluorobiphenyl-3')-acetic acid, 98.0%, 5g

METHYL 2-(5-BROMO-3-METHOXYPYRIDIN-2-YL)ACETATE, 95.0%, 250mg

Ethyl 3-formylbenzoate, 95+%, 100mg

4-Amino-1-methyl-1H-pyrazole-3-carboxylic acid, 97%, 250mg

Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate, 95.0%, 1g

2-(7-BOC-7-AZASPIRO[3.5]NONAN-2-YL)ACETIC ACID, 95.0%, 5g

SALVIANOLIC ACID A, 95%, 25mg

Long working distance plan phase 10x/0.25 IOS objective, working distance 7.45 mm

Ethyl 4,4-dimethyl-3-oxopentanoate, 95.0%, 25g

Methyl 4-chloro-6-(trifluoromethyl)nicotinate, 97%, 500mg

4-Isopropoxy-N-(2-methylquinolin-8-yl)benzamide, 97.0%, 1g